10.00 Welcome message from Ing. Mauro Melis, CEO IEO, prof Roberto Orecchia scientific director IEO

Similar documents
EORTC MELANOMA GROUP MEETING

EORTC MELANOMA GROUP MEETING

EORTC MELANOMA GROUP MEETING

2 nd ESSO Advanced Course on the Surgical and Medical Management of Melanoma

SKIN MELANOMA September 2006, Istanbul, TR

10 th EADO Congress Vilnius, 7-10 May Ipilimumab update. Michele Maio

Cambia l algoritmo terapeutico

ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April :10 14:20 Room C

Promises and challenges of developing new drugs in oncology

Workshop: La Medicina Telematica per la disabilità è una realtà: chi, dove e quando. Esperienze di teledermatologia a Modena

Second European School of Dermato- Fundamentals of cutaneous oncology

ESSO Advanced Course on Oncoplastic Breast Surgery June 2016

GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT

ESSO Course on Peritoneal Surface Malignancy

Scientific Programme

2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom

Promises and challenges of developing new drugs in oncology

Curriculum Vitae - Sara Gandini

NAPLES - DECEMBER 5-6, 2011 Hotel San Francesco al Monte

APRIL 30TH-MAY 2ND MILAN - ITALY CHAIRMEN

APRIL 30TH-MAY 2ND MILAN - ITALY CHAIRMEN

Melanoma: assessment and management of melanoma

GUSTAVE ROUSSY AT ASCO

TEACH Summer School Cascais, Portugal 3-7 July, Training and Education for Advanced Clinicians and HCPs in Personalised Medicine

RESEARCH EDUCATE ADVOCATE. Just Diagnosed with Melanoma Now What?

Elu Epidemic outbreaks and Their Effect on the Global Economy

Regional Young Investigator SIC meeting. 5-6 March 2015

ONCOLOGY NURSING 7 TH ESO-EONS MASTERCLASS IN March 2014 Ermatingen (Lake Constance) Switzerland MASTERCLASS

Pharmacogenomics and theranostics in practice

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1

NEW ALLIANCE FOR EUROPEAN EXCELLENCE AND COMPETITIVENESS IN LIFE SCIENCES

PULMONARY HYPERTENSION. This meeting is fully sponsored by GlaxoSmithKline and jointly organised with the Meeting Faculty and GlaxoSmithKline

Breast. Patient information. cancer clinical pathway

Magnetic Resonance Techniques in Multiple Sclerosis

on End Stage Focus on Idiopathic

Melanoma Independent board SECOND MELANOMA MIB CONFERENCE 2014 October on INNOVATION AND SUSTAINABILITY. Innovation

E UROPEAN PERSONAL INFORMATION

Foundational Issues Related to Immunotherapy and Melanoma

How To Learn More About Melanoma

A European network on cervical cancer surveillance and control in the new Member States - AURORA

Research Methods for Respiratory Diseases

INTERNATIONAL RETREAT OF PhD STUDENTS IN IMMUNOLOGY June 2015

ORGANIZERS Fundación para la Investigación Médica Aplicada FIMA Clínica Universidad de Navarra CUN

Immunotherapy of Uveal Melanoma

BOLOGNA - Italy OCTOBER,

AWLP Lymphoma Course and Workshop 9-10 November 2011 Hilton, Cardiff City Centre PROGRAMME

ECPC ANNUAL GENERAL ASSEMBLY

INTERDISCIPLINARY CONFERENCE. Florence/Firenze, Italy Nov 27-29, 2012 Centro Congressi al Duomo, Firenze BREAST SEMINAR SERIES

Magnetic Resonance Techniques in Neurodegenerative Diseases First Course Alzheimer s disease and frontotemporal lobar degeneration spectrum

Programme. Michele Grieco Dipartimento di Scienze Ambientali Seconda Università degli Studi di Napoli Naples, Italy

WORKSHOP IN LUNG CANCER CLINICAL RESEARCH Improving opportunities in the LATAM region

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

Understanding the Molecular and Cellular Biology of Endocrine-Related Cancers. Mont Ste. Odile, Alsace, France September 2008

The Management. 15 th December, VENICE Hotel Palazzo Giovanelli Santa Croce, San Stae, Workshop on

AOSpine Masters Symposium Adult deformity of the cervical, thoracic and lumbar spine

New Frontiers. in Glaucoma. Management. Rome, 7 February 2014 Donna Camilla Savelli Hotel

What s New in Rhinology 2012

E UROPEAN CURRICULUM VITAE FORMAT

Departments of Nuclear Medicine, Surgery, and Endocrinology University of Ulm

Mediterranean School of Oncology

Best of San Antonio Breast Cancer Symposium

Early mortality rate (EMR) in Acute Myeloid Leukemia (AML)

Milan Meeting Agenda October 27th 29th, 2010

MAY AUDITORIUM DEL SERAPHICUM. Via del Serafico, 1 - ROME - ITALY PRELIMINARY PROGRAM. Chairman: Giovanni Di Giacomo, MD

Henrique Prata Barretos Cancer Hospital Brazil

Overall teaching planning and Istitutional tasks Antonio Cuneo (Hematology), Giovanni Lanza (Pathology)

IFHNOS WORLD TOUR 2012

pulmonary hypertension bologna 2012 Royal Hotel Carlton - Bologna - Italy Under the aegis of alma mater studiorum università di bologna

Santa Maria Annunziata Hospital / Azienda Sanitaria di Firenze

PRELIMINARY PROGRAM. MELANOMA BRIDGE 2015 Hotel Excelsior, Naples, Italy Sala Partenope December 1-4, 2015

SIOP ACCELERATING THE DEVELOPMENT OF NEW ONCOLOGY DRUGS FOR CHILDREN AND ADOLESCENTS BRUSSELS, BELGIUM JANUARY 2016

7 th Course on Paediatric Reconstructive Urology HOW WE DO IT. Rome, June 2012

APRIL 30TH-MAY 2ND MILAN - ITALY CHAIRMEN

International Symposium on Malignant Pleural Mesothelioma

ENVISIONING THE FUTURE OF DERMATOLOGY THROUGH THE LENS OF MEDICAL INFORMATICS

Advances in Biology and Treatment of Malignant Brain Gliomas

Cachexia and Nutrition in Advanced Cancer Patients: a Multidisciplinary Approach Chairs: M.S. Aapro, CH J. Herrstedt, DK F.

MEETING 2NEW STRATEGIES KIDNEY CANCER TREATMENT AND TRANSPLANT SURGERY. Rome September 28-30, 2015 POLICLINICO TOR VERGATA FOUNDATION ROME, ITALY

Scientific Programme

Advances in Lung Cancer: A Multidisciplinary Approach

NICE guideline Published: 29 July 2015 nice.org.uk/guidance/ng14

2011 IRCC International Conference Molecular Clinical Oncology May 26th-28th, 2011, Torino Italy

Trials in Elderly Melanoma Patients (with a focus on immunotherapy)

Financialisation and sustainability

Milano, 9-12 Luglio 2012 Hotel Enterprise

September 5, Linda Stewart Vice President, National Lab Program UnitedHealthcare Group P.O. Box 1459 Minneapolis, MN

Scientific Committee. Andrés Cervantes (ESMO, GEICO) Antonio González (ESMO, GEICO) Andrés Poveda (ESMO, GEICO) Jan B. Vermorken (ESMO, GEICO)

The CASP8 rs polymorphism and breast cancer risk in BRCA1 mutation carriers.

CLINICAL ONCOLOGY MASTERCLASS IN April 2015 São Paulo, Brazil. Chairs: Scientific Co-ordinators: ESO - LATIN-AMERICAN PROGRAMME

STRESA 31/03/11 RARE SOLID CANCERS: AN INTRODUCTION. 31 March - 1 April 2011 Stresa, Italy. Chairs: P.G. Casali, IT - G. Gatta, IT

BIG DATA Driving Evidence for Healthcare Thursday, 5 March :30 17:45 Lecture Hall Pathology C

MOLOGEN AG. Q1 Results 2015 Conference Call Dr. Matthias Schroff Chief Executive Officer. Berlin, 12 May 2015

MODERN MANAGEMENT OF UTERINE MYOMAS

UPDATE ON BONE METASTASES

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

CANCER IN THE ELDERLY

Soil Biological Communities and Aboveground Resilience

POST-CONGRESS SATELLITE MEETINGS May 24 th, Cancer biomarkers 2013

Gentofte Workshop. Gentofte. Hospital 10/2012. University. Training Centre

Transcription:

EORTC MELANOMA GROUP MEETING Milano April 29th-30th, 2016 Host: Alessandro Testori (Istituto Europeo di Oncologia, Milano, Italy) alessandro.testori@ieo.it Group chair: Caroline Robert (Institute Gustave Roussy, Paris, France) Website : www.melanomagroup.eu Agency supporting the logistics: Moira Boccia (eortc.deaeventi@gmail.com) piazza cavallotti, 2 00040 Castel gandolfo (RM) tel 06 9360565 fax 06 93590149 April 28 th 18:00-22:00 Steering Committee Meeting Hotel HNOW Milano, Via Tortona, 35 - (sala PANAMA, 1 Piano) Steering members: Cook Martin, De Schaetzen Gaetan, Eggermont Alexander, Franks Hester, Gandini Sara, Ghanem Ghanem, Leyvraz Serge, Lorigan Paul, Marreaud Sandrine, Mihm Martin, Puig Susana, Robert Caroline, Schadendorf Dirk, Schilling Bastian, Suciu Stefan, Testori Alessandro, Van Akkooi Alexander, Van Kempen Leon. Invited: Francesca Martinelli, EORTC HQ Brussels Maria-José Passos, Fall meeting organizer in Lisbon April 29 th venue IEO (via Ripamonti 435), room Leonardo La Pietra 10.00 Welcome message from Ing. Mauro Melis, CEO IEO, prof Roberto Orecchia scientific director IEO Plenary session 1 (4 x 20 presentation + 10 minutes discussion) Chair: Alessandro Testori (Milano) & Caroline Robert (Paris) (4 x 20 presentation + 10 discussion) open to non members and company employees 10.10 Combination approach between locoregional treatment and immunotherapy Paolo Ascierto (Napoli) 10.30 UK margins study, commentary by Marc Moncrieff (Norwich) 10.50 innovative study with combination of new drugs. Michele Maio (Siena) 11.10 Phase I Agenus studies report. Dr Robert Wesolowski, MD, Assistant Professor, Internal Medicine, College of Medicine and Director of Phase I Clinical Trials for the Division of Medical Oncology at the James Cancer Center at Ohio State University. 11,30 Discussion Plenary session 2 Chair: Sara Gandini (Milano) & Susana Puig (Barcelona) (3 x 12 presentation + 3 discussion) open to non members and company employees 11.50 Molecular pathology in melanoma. Massimo Barberis (Milano) 12.05 Confocal microscopy in the intraoperative setting. Josef Malvehy (Barcelona) EORTC Melanoma Group spring meeting Milan 2016 - Page 1

12:20 Recent developments of the Melanoma Quality of Life questionnaire. Francesca Martinelli (EORTC, Brussels) 12.35 Discussion 13.00-13.40 LUNCH Afternoon sessions: restricted to group members only; non members by invitation 13.40-15.10 Break-out sessions Chaired by subgroup chairs Epidemiology, Early Stage, Surgery, Pathology, Ocular, Systemic (Stage IV and Adjuvant) - Epidemiology + Early stage/dermatology room direzione scientifica ground floor central corridor - 14.00-14.30 Surgery + Pathology room B ground floor - 14.30-15.30 surgery room B - 14.30-15.30 pathology room sala Consiglio ground floor right side IEO. - Ocular, systemic (adjuvant and stage IV) aula Leonardo La Pietra 15.10-16.30 Plenary Session Chair: A. Van Akkooi (Amsterdam) & D. Schadendorf (Essen) (open to non-members and company employees) Ongoing research in members Institutions Presentation of Selected Abstracts (7 presentation + 3 discussion) 1. Neo-adjuvant versus adjuvant immunotherapy in melanoma: preliminary results of the OPACIN trial. Max Madu, Netherlands Cancer Institute, Amsterdam 2. Indocyanin green and multispectral optoacoustic imaging can replace radioactive lymphoscintigraphy and histology in sentinel lymph node detection and determination. Joachim Klode, University Hospital, Essen 3. Timing of Completion Lymphadenectomy After Positive Sentinel Node in Melanoma Patients: Effect on Survival? Charlotte Oude Ophuis, Erasmus MC Cancer Institute, Rotterdam 4. FDG-PET surveillance imaging in high-risk melanoma patients: time for change? Max Madu, Netherlands Cancer Institute, Amsterdam 5.Mx1 incomplete loss in primary ulcerated melanoma: an observation that may help explain IFN± sensitivity of ulcerated melanoma? Camila Flores, Institue Gustave Roussy, Paris 6.PROPANOLOL FOR OFF-LABEL TREATMENT OF MELANOMA PATIENTS: A proof-ofconcept prospective cohort study. Vincenzo de Giorgi, University of Florence, Italy 7.Cytoreductive treatment with BRAF + MEK inhibition of unresectable stage III melanoma is very promising: preliminary results of the REDUCTOR trial. Max Madu, Netherlands Cancer Institute, Amsterdam 8.Intratumoural treatment with LTX-315, an oncolytic peptide immunotherapy, in patients with advanced metastatic disease induces infiltration of CD8 effector T-cells and regression in some injected tumours. Jean-Francois Baurain, Saint-Luc University Hospital Brussels, Belgium EORTC Melanoma Group spring meeting Milan 2016 - Page 2

16.30-17.10 Study Proposals (4 x 5 presentation + 5 discussion) 17.10-17.20 Coffee Break 17.20-18.20 HQ trial reports - Aula Leonardo la Pietra (restricted to group members) Chair A. Van Akkooi (Amsterdam) 18.20-19.20 Sub-Committee Reports & Decision Making / Voting on New Proposals (restricted to group members) 19.20 Group Dinner (bus transfer to the country house of Testori s family) April 30 th Parallel Courses 8.00-11.00 (Click on title or Browse down) Pathology Course - Confocal Microscopy Course Pathology & Dermatology Working group Meeting 11.00 Coffee break 11.20-13.00 Pathology-dermoscopy & Confocal combined Course Aula Leonardo La Pietra Cases illustrated by: D. Massi, M. Mihm, M. Cook, S. Puig, J. Malvehy, G. Pellacani, C. Longo, G. Spadola, I. Stanganelli. 13.30 Lunch & Meeting Closure EORTC Melanoma Group spring meeting Milan 2016 - Page 3

Melanoma Pathology Working Group Meeting for European Dermatopathologists and Pathologists Milan, Italy April 30, 2016 Local Host: Alessandro Testori, Istituto Europeo di Oncologia, Milan Course Moderators: Daniela Massi, M.D. Associate Professor of Pathology Division of Pathological Anatomy University of Florence Florence, Italy Martin Cook, M.D. Chairman, EORTC Melanoma Pathology Group Royal County Surrey Hospital Guildford, UK Course Location: Istituto Europeo di Oncologia, aula B ground floor, Via Ripamonti 435, Milano. No Fee to Attend. European CME credits by the EACCME (European Accreditation Council for Continuing Medical Education) will be requested. If you wish to attend, please register (before February 28 th 2016) through our website: www.melanomagroup.eu In case of questions, please e-mail to: eortc.deaeventi@gmail.com

Scientific Programme 8.00-11.00 aula B ground floor Teaching Course faculty: Willeke Blokx, Nijmegen, The Netherlands Martin Cook, Guilford, UK Senada Koljenovic, Rotterdam, The Netherlands Daniela Massi, Florence, Italy Giovanni Mazzarol, Milan, Italy Martin C. Mihm, Boston, USA Joost van der Oord, Leuven, Belgium Pathological Staging in Cutaneous Melanoma: Problematic Areas This course is designed to bring to light problematic areas related to pathological staging of cutaneous melanoma using a case-based approach. Topics include the recognition of regression, the estimation of tumor infiltrating lymphocytes (TILs) and ulceration, proper handling and interpretation of sentinel lymph nodes in melanoma patients. Incorrect interpretation and poor standardization of these parameters have strong implications on patients clinical management and can dramatically impact on the recruitment of melanoma patients in EORTC clinical trials. The course will be presented in a case-based format. Pre-registrants will be able to view virtual slides prior to the meeting. the participants will be encouraged to submit their most appropriate answers in advance to facilitate a more lively discussion during the course with active participation from the audience. 8.00-8.15 Case 1 TILs (M. Mihm) 8.15-8.30 Case 2 TILs (M. Mihm) 8.30-8.45 Case 3 Regression (G. Mazzarol) 8.45-9.00 Case 4 Regression (J. van den Oord) 9.00-9.15 Case 5 Breslow (W. Blokx) 9.15-9.30 Case 6 Ulceration (W. Blokx) 9.30-9.45 Case 7 SLN evaluation (S. Koljenovic) 9.45-10.00 Case 8 SLN evaluation (S. Koljenovic) 10.00-10.15 Case 9 SLN evaluation (M. Cook) 10.15-10.30 Case 10 SLN evaluation (M. Cook) 10.30-11.00 Discussion

Message from the Chairman of the EORTC Melanoma Pathology Group The Teaching Courses of the EORTC Melanoma Pathology now represent a regular component of the EORTC Melanoma Group meetings. The main educational aim is to enhance the participants professional competence in the diagnosis of melanocytic lesions providing information on current standardized protocols, criteria, classifications and share, in a friendly and enthusiastic atmosphere, basic science information and novel experimental data. Virtual slides allow the participants to review the cases and express their opinions prior to the meeting, in order to enhance discussion and active participation. In Milan, emphasis will be placed to the complex assessment of sentinel lymph nodes, a topic that will be discussed in presence of an internationally-recognized faculty. Looking forward to seeing you in Milan, Prof. Martin Cook Chairman EORTC Melanoma Pathology Group

Melanoma Confocal Working Group Meeting for European Dermatopathologists and Dermatologists Milan, Italy April 30, 2016 Local Host: Giuseppe Spadola and Alessandro Testori Istituto Europeo di Oncologia, Milan Course Moderators: Susana Puig, M.D. Chairwoman EORTC Early Stages Melanoma Group Associate Professor of Dermatology Chief Dermatology Department Hospital Clinic, University of Barcelona Barcelona, Spain Giovanni Pellacani, MD Chief Dermatology Department Professor of Dermatology University of Modena, Italy Josep Malvehy, M.D. Associated Professor Chief Melanoma Unit Hospital Clinic, University of Barcelona Barcelona, Spain Caterina Longo, M.D. Dermatologist Reggio Emilia & Modena University, Italy Ignazio Stanganelli, MD Dermatologist Emilia-Romagna, Italy Course Location: Istituto Europeo di Oncologia, aula Leonardo La Pietra, ground floor,via Ripamonti 435, Milano. No Fee to Attend. European CME credits by the EACCME (European Accreditation Council for Continuing Medical Education) will be requested. If you wish to attend, please register (before February 28 th 2016) through our website: www.melanomagroup.eu In case of questions, please e-mail to: eortc.deaeventi@gmail.com

Reflectance Confocal Microscopy in Melanoma: From basic criteria to clinical application in daily practice Scientific Programme (aula Leonardo La Pietra) 8.00-11.00 This course is designed to bring to light reflectance confocal microscopy criteria for the diagnosis in cutaneous melanoma using a case-based approach. Topics include the recognition of suspicion criteria and pitfalls, both for beginners and more advanced users. The course will be presented in a case-based format. Pre-registrants will be able to view virtual cases prior to the meeting. The participants will be encouraged to submit their most appropriate answers in advance to facilitate a more lively discussion during the course with active participation from the audience. Teaching course faculty: Martin Cook, Guildford, UK Caterina Longo, Reggio Emilia, Italy Martin Mihm, Boston, USA Josep Malvehy, Barcelona, Spain Daniela Massi, Florence, Italy Giovanni Pellacani, Modena, Italy Susana Puig, Barcelona, Spain Giuseppe Spadola, Milan, Italy Ignazio Stanganelli, Emilia-Romagna, Italy Scientific Programme 8.00-8.15 Introduction and principles of in vivo and ex vivo confocal technology (G. Pellacani) 8.15-8.45 Confocal microscopy criteria and histopathological correlate (C. Longo) 8.45-9.15 Diagnosis of melanocytic lesions (S. Puig) 9.15-9.45 Diagnosis of non melanocytic tumours (J. Malvehy) 9.45-10.30 Confocal microscopy in the clinical practice (Coordinated by G. Spadola and Ignazio Stanganelli) Cases discussed by G. Pellacani, C. Longo, S. Puig and J. Malvehy 10.30-11.00 Discussion 11.00 coffee break

Message from the Chairman of the EORTC Melanoma Early Stage Group The Teaching Courses of the EORTC Melanoma group now represent a regular component of the EORTC Melanoma Group meetings. The main educational aim is to enhance the participants professional competence in the diagnosis and management of melanocytic lesions. In this sense, the Reflectance Confocal Microscopy course is incorporated in the present meeting as complement of the case based discussion cases performed in the previous edition of the dermatopathology course. Virtual cases will allow the participants to review the cases and express their opinions prior to the meeting, in order to enhance discussion and active participation. In Milan, cases will be discussed together with expert pathologist in the field. Looking forward to seeing you in Milan, Prof. Susana Puig Chairman EORTC Melanoma Early Stage Group

Melanoma Pathology & Dermatology Working Group Meeting for European Dermatologists and Pathologists Milan, Italy April 30, 2016 Local Host: Giovanni Mazzarol and Giuseppe Spadola Course Moderators: Daniela Massi, M.D. Associate Professor of Pathology Division of Pathological Anatomy University of Florence Florence, Italy Susana Puig, M.D. Chair EORTC Early Stages Melanoma Group Associate Professor of Dermatology Chief Dermatology Department Hospital Clinic, University of Barcelona, Spain Martin Cook, M.D. Chairman, EORTC Melanoma Pathology Group Royal County Surrey Hospital Guildford, UK Giovanni Pellacani, MD Chief Dermatology Department Professor of Dermatology University of Modena, Italy Course Location: Istituto Europeo di Oncologia, aula Leonardo La Pietra, Via Ripamonti 435, Milano. Reflectance Confocal Microscopy in Melanoma: From basic criteria to clinical application in daily practice. This course is designed to bring to light reflectance confocal microscopy criteria for the diagnosis in cutaneous melanoma using a case-based approach. Topics include the recognition of suspicion criteria and pitfalls, both for beginners and more advanced users. The course will be presented in a case-based format and will give insights into confocal/dermoscopy-pathology correlations. Pre-registrants will be able to view virtual cases,

including digital histopathological slides, prior to the meeting. The participants will be encouraged to submit their most appropriate answers in advance to facilitate a more lively discussion during the course with active participation from the audience. Participants will learn to recognize confocal and dermoscopic structures, their histologic correlates, focusing on criteria that are essential in helping clinicians classify skin lesions as benign or malignant. Teaching faculty: Willeke Blokx, Nijmegen, The Netherlands Martin Cook, Guilford, UK Senada Koljenovic, Rotterdam, The Netherlands Caterina Longo, Reggio Emilia, Italy Josep Malvehy, Barcelona, Spain Daniela Massi, Florence, Italy Giovanni Mazzarol, Milan, Italy Martin C. Mihm, Boston, USA Giovanni Pellacani, Modena, Italy Susana Puig, Barcelona, Spain Giuseppe Spadola, Milan, Italy Ignazio Stanganelli, Emilia-Romagna, Italy Joost van der Oord, Leuven, Belgium If you wish to attend, please register (before February 28th 2016) through our website: www.melanomagroup.eu